CONCENTRATION OF PLASMINOGEN ACTIVATORS AND INHIBITOR IN THE HUMAN ENDOMETRIUM AT DIFFERENT PHASES OF THE MENSTRUAL-CYCLE

被引:0
作者
KOH, SCL
WONG, PC
YUEN, R
CHUA, SE
NG, BL
RATNAM, SS
机构
来源
JOURNAL OF REPRODUCTION AND FERTILITY | 1992年 / 96卷 / 02期
关键词
PLASMINOGEN ACTIVATORS; UROKINASE; PLASMINOGEN ACTIVATOR INHIBITOR; ENDOMETRIUM; HUMAN;
D O I
暂无
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
The concentrations of tissue plasminogen activator (t-PA), urokinase plasminogen activator (u-PA) and plasminogen activator inhibitor (PAI-1) have been determined in endometrial curettings obtained from 46 subfertile women during proliferative, early or late secretory phases of the menstrual cycle. t-PA activity and antigen concentrations was significantly higher (P < 0.001) in late secretory endometrium than in proliferative or early secretory endometrium. Higher concentrations of PAI-1 antigen (P < 0.05) were also noted in late secretory phase than in proliferative and early secretory endometrium. However, u-PA concentration was not significantly different and no PAI activity could be demonstrated in the menstrual phases studied. Zymography studies confirmed the presence of both t-PA and u-PA in the endometrium. Ovarian hormonal patterns may therefore influence the activity of plasminogen activators especially of t-PA in the endometrium during various phases of the menstrual cycle.
引用
收藏
页码:407 / 413
页数:7
相关论文
共 18 条
  • [1] RADIOIMMUNOASSAY OF UROKINASE FOR QUANTIFICATION OF PLASMINOGEN ACTIVATORS RELEASED IN OVARIAN TUMOR CULTURES
    ASTEDT, B
    HOLMBERG, L
    LECANDER, I
    THORELL, J
    [J]. EUROPEAN JOURNAL OF CANCER, 1981, 17 (02) : 239 - 244
  • [2] FIBRINOLYTIC-ACTIVITY OF HUMAN UTERINE FLUID
    CASSLEN, B
    ASTEDT, B
    [J]. ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 1981, 60 (01) : 55 - 58
  • [3] REDUCED PLASMINOGEN-ACTIVATOR CONTENT OF THE ENDOMETRIUM IN ORAL-CONTRACEPTIVE USERS
    CASSLEN, B
    ASTEDT, B
    [J]. CONTRACEPTION, 1983, 28 (02) : 181 - 188
  • [4] OCCURRENCE OF BOTH UROKINASE AND TISSUE PLASMINOGEN-ACTIVATOR IN THE HUMAN-ENDOMETRIUM
    CASSLEN, B
    ASTEDT, B
    [J]. CONTRACEPTION, 1983, 28 (06) : 553 - 564
  • [5] PLASMINOGEN ACTIVATORS, TISSUE DEGRADATION, AND CANCER
    DANO, K
    ANDREASEN, PA
    GRONDAHLHANSEN, J
    KRISTENSEN, P
    NIELSEN, LS
    SKRIVER, L
    [J]. ADVANCES IN CANCER RESEARCH, 1985, 44 : 139 - 266
  • [6] STUDY OF PROTEASES AND PROTEASE-INHIBITOR COMPLEXES IN BIOLOGICAL-FLUIDS
    GRANELLIPIPERNO, A
    REICH, E
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1978, 148 (01) : 223 - 234
  • [7] SECRETION OF PLASMINOGEN ACTIVATOR BY HUMAN POLYMORPHONUCLEAR LEUKOCYTES - MODULATION BY GLUCOCORTICOIDS AND OTHER EFFECTORS
    GRANELLIPIPERNO, A
    VASSALLI, JD
    REICH, E
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1977, 146 (06) : 1693 - 1706
  • [8] PROGESTOGEN REGULATION OF TISSUE PLASMINOGEN-ACTIVATOR IN A HUMAN-MELANOMA CELL-LINE
    KJAELDGAARD, A
    AHLESTEEN, I
    LARSSON, B
    ASTEDT, B
    [J]. THROMBOSIS RESEARCH, 1988, 49 (02) : 287 - 297
  • [9] UTERINE PLASMINOGEN-ACTIVATOR ACTIVITY - MODULATION BY STEROID-HORMONES
    KNEIFEL, MA
    LEYTUS, SP
    FLETCHER, E
    WEBER, T
    MANGEL, WF
    KATZENELLENBOGEN, BS
    [J]. ENDOCRINOLOGY, 1982, 111 (02) : 493 - 499
  • [10] KOH S C L, 1989, Medical Science Research, V17, P135